backgrounddevelop
uncommon
viral
infect
immunocompromis
transplant
recipi
pose
major
diagnost
challeng
present
case
report
immunocompromis
patient
suffer
pneumonia
caus
agent
identifi
routin
method
objectivesto
identifi
potenti
caus
pneumonia
use
degener
oligonucleotid
primer
dop
pcr
assay
design
detect
virus
studi
designdoppcr
appli
bronchoalveolar
lavag
fluid
patient
gener
pcr
product
clone
sequenc
resultsth
novel
univers
viru
assay
detect
human
metapneumoviru
clinic
sampl
find
confirm
two
independ
metapneumoviru
specif
pcr
target
independ
region
viral
genom
conclusionsth
dop
pcr
use
detect
identifi
sequenc
unidentifi
viru
studi
provid
proof
concept
use
clinic
relev
specimen
unbias
univers
assay
requir
previou
viral
sequenc
inform
detect
unknown
virus
remain
one
challeng
problem
virolog
classic
method
fail
detect
virus
develop
molecular
test
depend
upon
avail
accur
sequenc
inform
gener
viru
detect
test
allow
simultan
detect
multipl
viru
sequenc
previous
develop
optim
improv
univers
viru
detect
method
sensit
broadli
detect
dna
rna
virus
infect
cell
cultur
spike
cell
limit
amount
nucleic
acid
virus
techniqu
requir
prior
sequenc
inform
viru
detect
impli
promis
viru
discoveri
detect
viru
sampl
method
fail
case
pulmonari
infiltr
fever
unknown
origin
occur
hematopoiet
stem
cell
transplant
hsct
recipi
investig
use
modifi
version
gener
viru
detect
assay
convent
method
fail
identifi
pathogen
preced
studi
bronchoalveolar
lavag
bal
fluid
neg
typic
respiratori
pathogen
use
standard
microbiolog
techniqu
includ
bacteria
includ
nocardia
legionella
mycoplasma
chlamydophila
mycobacteria
fungi
pneumocysti
routin
viral
studi
influenza
b
adenoviru
parainfluenza
herp
simplex
viru
cytomegaloviru
respiratori
syncyti
viru
also
neg
aliquot
previous
test
bal
obtain
store
refriger
temperatur
sever
day
storag
condit
might
damag
viru
capsid
thu
made
viral
nucleic
acid
vulner
nucleas
digest
modifi
previous
describ
purif
procedur
elimin
use
nucleas
method
base
physic
separ
host
viru
nucleic
acid
follow
degener
oligonucleotid
primer
pcr
doppcr
optim
viruss
genom
permit
nonspecif
nucleic
acid
amplif
high
degre
sensit
copi
viral
nucleic
acid
pcr
use
singl
primer
popul
short
conserv
sequenc
tgtgg
sever
log
sensit
previous
describ
nonspecif
viral
pcr
assay
doppcr
experiment
shown
amplifi
rang
viral
genom
includ
dna
virus
hsv
vzv
ebv
adenoassoci
viru
rna
virus
polioviru
influenza
viru
research
deem
exempt
offic
human
subject
research
nih
perform
accord
ethic
standard
fda
nih
institut
review
board
helsinki
declar
modifi
two
bal
aliquot
centrifug
g
hr
dna
rna
separ
extract
supernat
pellet
allprep
dnarna
kit
qiagen
valencia
ca
cdna
synthes
carri
use
first
strand
kit
random
hexam
primer
invitrogen
carlsbad
ca
doppcr
carri
separ
dna
cdna
purifi
one
bal
aliquot
reaction
contain
mm
mgcl
mm
kcl
mm
tri
ph
dntp
dop
primer
u
low
dna
taq
appli
biosystem
foster
citi
ca
cycl
condit
min
cycl
min
min
slow
ramp
min
extens
cycl
min
min
min
extens
addit
second
per
cycl
extens
step
doppcr
product
analyz
purifi
gel
electrophoresi
result
cdna
shown
figur
four
individu
band
purifi
cdna
amplif
ligat
topota
clone
vector
transform
compet
bacteria
invitrogen
carlsbad
ca
doppcr
dna
extract
bal
yield
nondiscret
smear
consist
nonspecif
amplif
cellular
nucleic
acid
analyz
sequenc
perform
use
genet
analyz
appli
biosystem
foster
citi
ca
sequenc
obtain
clone
compar
nonredund
nr
databas
genbank
use
tblastx
ncbi
bethesda
md
primer
sequenc
hmpv
specif
pcr
ngene
forward
primer
ggyracyttrctwaargaatcatcagg
ngene
revers
primer
cagattcrggrcccatytctc
lgene
forward
primer
cttgagatggtattaaatga
lgene
revers
primer
cctacacttaattctctttc
pcr
cycl
condit
min
cycl
sec
min
min
follow
min
sequenc
dna
four
band
repres
doppcr
product
deriv
cdna
five
clone
doppcr
yield
sequenc
match
known
sequenc
ggene
human
metapneumoviru
figur
largest
band
bp
yield
human
mitochondri
sequenc
second
band
bp
yield
two
human
mitochondri
sequenc
two
hmpv
sequenc
third
band
bp
yield
one
human
sequenc
smallest
band
bp
yield
four
human
three
hmpv
sequenc
hmpv
sequenc
deriv
ggene
overlap
clone
contain
vector
sequenc
confirm
presenc
hmpv
sampl
duplic
bal
sampl
subject
independ
pcr
target
nucleoprotein
polymeras
gene
genom
region
primer
sequenc
chosen
degeneraci
permit
detect
seven
hmpv
full
length
genom
genbank
rtpcr
nucleoprotein
gene
test
posit
two
independ
supernat
pellet
sampl
lgene
polymeras
sequenc
detect
pellet
supernat
sampl
impli
lower
sensit
test
figur
rel
locat
doppcr
specif
pcr
product
shown
figur
detect
hmpv
sequenc
clinic
sampl
prove
conclus
viru
sole
caus
pneumonia
report
indic
viral
sequenc
may
persist
long
period
time
murin
lung
tissu
detect
hmpv
sequenc
could
repres
either
viabl
nonviabl
viru
particl
howev
detect
signal
supernat
well
pellet
impli
viru
capsid
free
viral
nucleic
acid
present
presenc
readilydetect
hmpv
sequenc
bal
fluid
use
gener
dop
assay
well
two
independ
pcr
differ
region
genom
impli
high
probabl
recent
ongo
hmpv
infect
individu
identifi
differ
overlap
doppcr
product
hmpv
ggene
detect
hmpv
gene
hmpv
sequenc
bias
way
would
support
preferenti
doppcr
amplif
ggene
thu
seem
like
sampl
contain
rna
ggene
gene
may
relat
refriger
storag
sampl
five
day
prior
analysiscondit
may
caus
signific
amount
rna
degrad
although
identif
hmpv
clinic
sampl
usual
major
diagnost
challeng
genet
heterogen
among
hmpv
strain
lead
fals
neg
rtpcr
assay
lead
investig
seek
improv
assay
find
impli
doppcr
base
univers
viru
assay
use
find
virus
patient
sampl
method
fail
identifi
pathogen
particularli
import
sampl
quantiti
limit
make
difficult
perform
mani
addit
test
singl
gener
assay
capabl
detect
dna
rna
viral
genom
pair
appropri
purif
techniqu
thu
signific
advantag
major
strength
dop
assay
abil
amplifi
viral
sequenc
without
prior
knowledg
sequenc
increas
likelihood
find
mutat
novel
virus
virus
substanti
sequenc
heterogen
includ
asyet
undiscov
unexpect
nonhuman
virus
major
import
emerg
infecti
diseas
select
agent
zoonot
origin
unlik
mani
subtractionbas
gener
approach
nonsubtract
dop
assay
requir
noninfect
otherwis
genet
ident
control
compar
amplif
methodolog
use
primer
base
consensu
sequenc
share
among
relat
virus
eg
use
discov
new
herp
virus
identifi
west
nile
viru
etiolog
agent
human
enceph
new
york
outbreak
dop
assay
requir
perform
multipl
assay
direct
differ
viru
famili
may
impract
sampl
limit
dop
assay
also
requir
accur
sequenc
inform
viru
includ
screen
order
establish
assay
consensu
primer
microarraybas
techniqu
recent
describ
altern
classic
virolog
method
use
identifi
new
arenaviru
viru
link
coloni
collaps
disord
bee
polyomaviru
play
role
human
merkel
cell
carcinoma
use
combin
degener
pcr
highthroughput
sequenc
approach
expens
readili
avail
enrich
viral
nucleic
acid
present
approach
permit
identif
viral
sequenc
even
tradit
sequenc
make
approach
access
laboratori
access
pcr
clone
standard
sequenc
doppcr
assay
requir
three
day
sampl
receipt
sequenc
doppcr
approach
promis
situat
sampl
limit
suspicion
viral
diseas
high
standard
viral
diagnost
test
neg
virus
substanti
genet
heterogen
initi
suspect
base
clinic
present
would
particularli
amen
detect
use
method
